Caitlin Kontulis
Directeur Financier/CFO chez PHIO PHARMACEUTICALS CORP.
Fortune : 7 769 $ au 31/05/2024
Postes actifs de Caitlin Kontulis
Sociétés | Poste | Début | Fin |
---|---|---|---|
PHIO PHARMACEUTICALS CORP. | Directeur Administratif | - | - |
Directeur Financier/CFO | - | - | |
Secrétaire Général | - | - |
Historique de carrière de Caitlin Kontulis
Anciens postes connus de Caitlin Kontulis
Sociétés | Poste | Début | Fin |
---|---|---|---|
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Comptroller/Controller/Auditor | 18/04/2011 | - |
Formation de Caitlin Kontulis
Bryant University | Undergraduate Degree |
Northeastern University | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Opérationnelle
Comptroller/Controller/Auditor | 1 |
Chief Administrative Officer | 1 |
Director of Finance/CFO | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
PHIO PHARMACEUTICALS CORP. | Health Technology |
Entreprise privées | 1 |
---|---|
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Health Technology |
- Bourse
- Insiders
- Caitlin Kontulis
- Expérience